Exogenus Therapeutics
PrivateLast Round
Strategic
Apr 24, 2024
Total Funding Raised
$1.32M
Company Overview
Exogenus Therapeutics is a biotechnology company developing an exosome-based platform technology designed to offer a pipeline of therapeutic products for skin and autoimmune diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Government Contracts, Revenue Share
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Exogenus Therapeutics Comparables
Compare Exogenus Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Lysatpharma GmbH | 84% | |
| ConvEyXO | 83% | |
| RION | 82% | |
Exogenus Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Strategic | Apr 24, 2024 | ||||
| Grant | Nov 9, 2022 | ||||
| Grant | Dec 30, 2019 | ||||
| Seed | Dec 10, 2015 | ||||
| Pre Seed | Aug 1, 2015 |
Exogenus Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| European Union's Horizon Research and Innovation program | Grant |
| 3xP Global | Strategic |
| COHiTEC Program | Accelerator |
| Criteria Capital Risc | Pre Seed, Seed |
| Blue Bio Value | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 15, 2026
Monthly visitors increased 1680% from 15 to 267.
- Dec 5, 2024
Grew 40% QoQ from 10 to 14 employees.
Exogenus Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Exogenus Therapeutics's valuation, stock price, and market status.